The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 9th 2024
Remission according to the simplified definition correlated with the 2016 preliminary gout remission definition and GIS score improvements.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Depression and Mood Influence Pain in Rheumatoid Arthritis Patients
Researchers report that in patients with rheumatoid arthritis (RA), greater positive mood throughout daily life was linked to less pain and fewer RA-related restrictions, while negative mood was linked to an increase in RA-related restrictions.
Symptom Severity Decreases in Patients with Psoriatic Arthritis who Undergo Weight-Loss Surgery
A retrospective analysis of patients who underwent bariatric surgery suggests that significant weight loss significantly lessens the symptoms of psoriasis and psoriatic arthritis.
Tofacitinib Effective for Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
In a post-hoc analysis, researchers found that the clinical efficacy of tofacitinib after 6 months of treatment was greater than placebo, and appeared similar regardless of methotrexate dose.
Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS
A review of six Phase 3 studies shows that tofacitinib is more effective for rheumatoid arthritis treatment than regimens including placebo and a disease modifying anti-rheumatic drug or methotrexate as monotherapy or in combination therapy.
Baricitinib Bested Adalimumab in Rheumatoid Arthritis Trial
In patients with active rheumatoid arthritis symtoms that persisted even though they were taking methotrexate, baricitinib (Lilly/Incyte) treatment led to "significant improvements" researchers reported at the American College of Rheumatology Annual Meeting in San Francisco, CA.
Sarilumab Plus DMARD Improves Fatigue, Pain for Patients with Rheumatoid Arthritis
Patients with rheumatoid arthritis who received sarilumab plus a DMARD who did not respond to anti-TNF medications showed statistically significant and clinically meaningful changes from baseline in fatigue, morning stiffness, pain, productivity, and participation at week 24.
Microbiome Seems to Have a Role in Triggering Lupus
A New York City research team believes that clinical SLE disease is associated with microbiome imbalances, specifically with decreases in the diversity and blooms of specific operational taxonomic units in the intestine.
Lupus Surveillance: Preliminary Results Show Strong Ethnic Differences
Estimates on the prevalence of systemic lupus erythematosus (SLE) in the US vary widely. To remedy that situation, the US Centers for Disease Control and Prevention supported four health departments and the Indian Health Service in efforts to get better data.
Some Lupus Patients at Risk for Gout Related to Diuretic Use
Although gout has historically been thought to be a rare in patients with SLE, a recent case series suggests that the incidence of gout in SLE may be greater than previously thought, University of Michigan researchers report.
New MAB Safe in Rheumatoid Arthritis Patients
Reporting at the American College of Rheumatology Annual Meeting in San Francisco, a team from Japan reported on a novel humanized monoclonal antibody called E6011, one that targets fractalkine-CX3CR1, with a research goal of stopping the chemokine's accumulation in inflamed tissues in rheumatoid arthritis.
Pathology Between Gout and Cardiovascular Events Remains a Mystery
The presence of urate crystal precipitation does not necessarily indicate a greater risk of cardiovascular complications for patients with increased levels of monosodium urate, which is the defining characteristic of gout.